HYPERURICEMIA
Clinical trials for HYPERURICEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERURICEMIA trials appear
Sign up with your email to follow new studies for HYPERURICEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a smartphone app help tame the 'Four Highs'?
Disease control Recruiting nowThis study is testing a smartphone app that gives personalized exercise plans to people with high blood pressure, high blood sugar, high cholesterol, and high uric acid (the 'Four Highs'). About 100 adults will use the app for six months to see if it helps them walk more and impr…
Matched conditions: HYPERURICEMIA
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated May 17, 2026 05:42 UTC
-
New hope for tough gout cases: experimental combo targets stubborn uric acid
Disease control Recruiting nowThis study tests a new drug called AR882 combined with a standard gout medication (XOI) in 25 adults with uncontrolled gout who had severe reactions or failed uricase therapy. The goal is to lower uric acid levels below 6 mg/dL and shrink painful uric acid crystal deposits (tophi…
Matched conditions: HYPERURICEMIA
Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New pill aims to lower uric acid in kidney patients
Disease control Recruiting nowThis study tests an experimental tablet called IG3018 in 60 adults with high uric acid, some of whom also have chronic kidney disease. The main goals are to check the drug's safety and see how well it lowers uric acid levels over 4 weeks. Participants will receive different doses…
Matched conditions: HYPERURICEMIA
Phase: PHASE1, PHASE2 • Sponsor: Intelligem Therapeutics Australia Pty Ltd. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New injection aims to tame 'Silent' high uric acid
Disease control Recruiting nowThis early-stage study tests an experimental drug called NNC4004-0002 in 60 adults with high uric acid but no symptoms. The main goal is to check if a single injection under the skin is safe and well-tolerated. Researchers will also measure how well it lowers uric acid levels. Pa…
Matched conditions: HYPERURICEMIA
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC